For the past decade, body mass index has been used to deny or delay abortion care, despite little evidence of increased ...

Novo Nordisk is betting on the future with a $2-billion deal to buy rights to a Chinese obesity drug. But investors remain unimpressed.

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

In countless reports and studies, obesity is often reduced to just a number: 42% of adults in the U.S. have obesity, ...

Policymakers should focus on both obesity prevention and better access to treatment for those already living with obesity.

Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also ...

From growth charts to anemia thresholds, clinical standards assume a single human prototype. Why are we still using ...

Below is a roundup of health tech and digital health news you may have missed | Keep up with some of the latest headlines in ...

Northwell Health partnered with Stacker to examine how rising prices for healthy foods impact low-income families, using data ...

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

Novo Nordisk rejoined the ABPI after a two-year suspension linked to promotional concerns. Audits confirmed compliance with ...

You can look at this chart online, or ask your vet for your pup’s score at ... inflammatory disease pretty much all the time,” Krebs said. “The biggest risk of obesity, or maybe the most concerning ...